WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006120564) PHARMACEUTICAL COMPOSITION COMPRISING AN ANTIVIRAL AGENT, AN ANTITUMORAL AGENT OR AN ANTIPARASITIC AGENT, AND AN ACTIVE AGENT SELECTED AMONG CARVEOL, THYMOL, EUGENOL, BORNEOL AND CARVACROL
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/120564    International Application No.:    PCT/IB2006/001328
Publication Date: 16.11.2006 International Filing Date: 15.05.2006
IPC:
A61P 31/12 (2006.01), A61P 33/00 (2006.01), A61P 33/10 (2006.01), A61P 35/00 (2006.01), A61K 45/06 (2006.01), A61K 31/045 (2006.01), A61K 31/05 (2006.01)
Applicants: ADVANCED SCIENTIFIC DEVELOPMENTS [MA/MA]; 10, rue Louksous, Quartier Longchamps, Casablanca 20200 (MA) (For All Designated States Except US).
REMMAL, Adnane [MA/MA]; (MA) (For US Only)
Inventors: REMMAL, Adnane; (MA)
Priority Data:
PCT/IB2005/001314 13.05.2005 IB
Title (EN) PHARMACEUTICAL COMPOSITION COMPRISING AN ANTIVIRAL AGENT, AN ANTITUMORAL AGENT OR AN ANTIPARASITIC AGENT, AND AN ACTIVE AGENT SELECTED AMONG CARVEOL, THYMOL, EUGENOL, BORNEOL AND CARVACROL
(FR) COMPOSITION PHARMACEUTIQUE COMPRENANT UN ANTIVIRAL , UN ANTITUMORAL OU UN ANTIPARASITAIRE, ET UN ACTIF CHOISI PARMI LE CARVEOL , LE THYMOL, L' EUGENOL, LE BORNEOL ET LE CARVACROL
Abstract: front page image
(EN)The invention relates to a pharmaceutical composition comprising at least one first active therapeutic substance selected among carveol, thymol, eugenol, borneol, carvacrol, alpha-ionone and beta-ionone, as well as isomers, derivatives and mixtures thereof, and comprising at least one second active therapeutic substance that is antitumoral. The invention is for use in the field of pharmaceutics.
(FR)L'invention concerne une composition pharmaceutique. La composition pharmaceutique de l'invention comprend au moins une première substance thérapeutiquement active choisie parmi le carvéol, le thymol, l'eugénol, le bornéol, le carvacrol, l'alpha-ionone et la bêta-ionone et les isomères et dérivés et mélanges de ceux-ci, et au moins une seconde substance thérapeutiquement active qui est un antitumoral. L'invention trouve application dans le domaine de la pharmacie.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: French (FR)
Filing Language: French (FR)